回復のための脳ネットワークをターゲットにする:脳卒中後の治療におけるマルチモダルのイノベーション
1Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown.
Stroke
|February 12, 2026
まとめ
このレビューでは,脳卒中後の脳ネットワークを標的とした新しい治療法を調査します. 戦略には,神経可塑性と回復を促進するためのナノ医療,神経刺激,AIが含まれています.
科学分野:
- 神経科学は神経科学である.
- バイオメディカルエンジニアリング
- 再生医学は,再生医療である.
背景:
- 脳卒中は,広範囲にわたる脳ネットワークの障害を引き起こし,機能的欠陥につながります.
- 神経可塑性によって引き起こされる,心筋梗塞周期のネットワークは,回復に極めて重要です.
- 現在の治療法では,ネットワークレベルの回復に対処する上で限界があります.
研究 の 目的:
- 脳卒中後の脳ネットワークをターゲットとする新興の治療戦略をレビューする.
- ナノ医療,バイオ材料,神経刺激の役割を強調する.
- 脳卒中回復におけるAIと機械学習の統合について議論する.
主な方法:
- 卒中回復と治療的介入に関する現在の文献のレビュー.
- ナノ医療,生体材料,神経刺激技術の分析.
- パーソナライズされた脳卒中リハビリテーションにおけるAI/MLアプリケーションの探索.
主要な成果:
- ナノ医療と生体材料は,神経可塑性を高めるための正確な配送を提供します.
- 非侵襲的な神経刺激は,補完的なネットワーク変調を提供します.
- AI/MLは,フィードバック主導のダイナミックな治療介入を可能にします.
結論:
- 新興の治療法は,脳卒中回復のために,心筋梗塞周辺のネットワークをターゲットにするという約束を示しています.
- バイオマテリアル,刺激,AIを統合した組み合わせアプローチは,脳卒中リハビリテーションを進める可能性が高い.
- AIによって駆動される精密医療は,個々の患者のニーズに対応した治療戦略を最適化します.
関連する概念動画
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Protein Networks
4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Protein Networks
2.9K
2.9K
Network Covalent Solids
16.2K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Muscle Recovery and Fatigue
4.3K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.3K


